Clinical significance of anti‐glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis

References

• Rutgers A., Heeringa P., Damoiseaux J. G., Cohen Tervaert J. W. ANCA and anti‐GBM antibodies in diagnosis and follow‐up of vasculitic disease. Eur J Int Med 2003; 14: 287–95
   PubMedGoogle Scholar
• Gallagher H., Kwan J. T. C., Jayne D. R. W. Pulmonary renal syndrome: a 4‐year, single‐center experience. Am J Kidney Dis 2002; 39: 42–7
   PubMed Web of Science ®Google Scholar
• Kluth D. C., Rees A. J. Anti‐glomerular basement membrane disease. J Am Soc Nephrol 1999; 10: 2446–53
   PubMed Web of Science ®Google Scholar
• Harrity P., Gilbert‐Barness E., Cabalka A., Hong R., Zimmerman J. Isolated pulmonary Goodpasture syndrome. Pediatr Pathol 1991; 11: 635–46
   PubMedGoogle Scholar
• Wanten G. J. A., Koolen M. I., Harthoorn‐Lasthuizen E. J., Van Liebergen F. J. H. M., Haverman J. F., Assmann K. J. M. Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti‐glomerular basement membrane disease. Neth J Med 1995; 47: 25–9
   PubMedGoogle Scholar
• Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–40
   PubMed Web of Science ®Google Scholar
• Dooley M. A., Aranow C., Ginzler E. M. Review of ACR renal criteria in systemic lupus erythematosus. Lupus 2004; 13: 857–60
   PubMed Web of Science ®Google Scholar
• Churg J., Sobin L. H. Renal disease: classification and atlas of glomerular disease. Igaku‐Shoin, Tokyo 1982
   Google Scholar
• Churg J., Bernstein J., Glassock R. J. Renal disease: classification and atlas of glomerular disease, 2nd edn. Igaku‐Shoin, New York 1995
   Google Scholar
• Akagi S., Ichikawa H., Suzuki J., Makino H. Systemic lupus erythematosus associated with cytomegalovirus infection. Scand J Rheumatol 2004; 33: 58–9
   PubMed Web of Science ®Google Scholar
• Berden J. H. Lupus nephritis. Kidney Int 1997; 52: 538–58
   PubMed Web of Science ®Google Scholar
• Bernstein K. A., Valerio R. D., Lefkowith J. B. Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 1995; 154: 2424–33
   PubMedGoogle Scholar
• Hylkema M. N., Van Bruggen M. C. J., Van de Lagemaat R., Kramers K., Berden J. H. M., Smeenk R. J. T. Heparan sulfate staining of the glomerular basement membrane in relation to circulating anti‐DNA and anti‐heparan sulfate reactivity: a longitudinal study in NZB/W F1 mice. J Autoimmun 1996; 9: 41–50
   PubMedGoogle Scholar
• Renaudineau Y., Révélen R., Dueymes M., Levy Y., Youinou P. Autoantibodies to heparan sulfate proteoglycans. Autoimmun Rev 2002; 1: 305–12
   PubMedGoogle Scholar
• Termaat R. M., Brinkman K., Nossent J. C., Swaak A. J. G., Smeenk R. J. T., Berden J. H. M. Anti‐heparan sulfate reactivity in sera from patients with systemic lupus erythematosus. Autoimmunity 1991; 82: 268
   Google Scholar
• Lefkowith J. B., Kiehl M., Rubenstein J., Valerio R. D., Bernstein K., Kahl L., et al. Heterogeneity and clinical significance of glomerular‐binding antibodies in systemic lupus erythematosus. J Clin Invest 1996; 98: 1373–80
   PubMed Web of Science ®Google Scholar
• Morioka T., Woitas R., Fujigaki Y., Batsford S. R., Vogt A. Histone mediates glomerular deposition of small size DNA anti‐DNA complex. Kidney Int 1994; 45: 991–7
   PubMedGoogle Scholar
• Lefkowith J. B., Gilkeson G. S. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 1996; 39: 894–903
   PubMed Web of Science ®Google Scholar
• Ghirardello A., Doria A., Zampieri S., Tarricone E., Tozzoli R., Villalta D., et al. Antinucleosome antibodies in SLE: a two‐year follow‐up study of 101 patients. J Autoimmun 2004; 22: 235–40
   PubMedGoogle Scholar
• Mohan C., Adams S., Stanik V., Datta S. K. Nucleosome: a major immunogen for pathogenic autoantibody‐inducing T cells of lupus. J Exp Med 1993; 177: 1367–81
   PubMed Web of Science ®Google Scholar
• Van Bruggen M. C. J., Kramers C., Hylkema M. N., Smeenk R. J. T., Berden J. H. M. Significance of antinuclear and anti‐extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol 1996; 105: 132–9
   PubMed Web of Science ®Google Scholar
• Herrmann M., Voll R. E., Zoller O. M., Hagenhofer M., Ponner B. B., Kalden J. R. Impaired phagocytosis of apoptotic cell material by monocyte‐derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1241–50
   PubMed Web of Science ®Google Scholar
• Emlen W., Neibur J., Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685–92
   PubMed Web of Science ®Google Scholar
• Tax W. J., Kramers C., Van Bruggen M. C., Berden J. H. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int 1995; 48: 666–73
   PubMedGoogle Scholar
• Benucci M., Gobbi F. L., Del Rosso A., Cesaretti S., Niccoli L., Cantini F. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol 2003; 32: 42–5
   PubMed Web of Science ®Google Scholar
• Burlingame R. W. Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clin Applied Immunol Rev 2004; 4351–66
   Google Scholar
• Burlingame R. W., Cervera R. Anti‐chromatin (anti‐nucleosome) autoantibodies. Autoimmun Rev 2002; 1: 321–8
   PubMedGoogle Scholar
• Zhao Z., Weinstein E., Tuzova M., Davidson A., Mundel P., Marambio P., et al. Cross‐reactivity of human lupus anti‐DNA antibodies with α‐actinin and nephritogenic potential. Arthritis Rheum 2005; 52: 522–30
   PubMedGoogle Scholar
• Mostoslavsky G., Fischel R., Yachimovich N., Yarkoni Y., Rosenmann E., Monestier M., et al. Lupus anti‐DNA autoantibodies cross‐react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 2001; 31: 1221–7
   PubMed Web of Science ®Google Scholar
• Seo P., Stone J. H. The antineutrophil cytoplasmic antibody‐associated vasculitides. Am J Med 2004; 117: 39–50
   PubMed Web of Science ®Google Scholar
• Csernok E. Anti‐neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2003; 2: 158–64
   PubMed Web of Science ®Google Scholar
• García‐Cantón C., Toledo A., Palomar R., Fernandez F., Lopez J., Moreno A., et al. Goodpasture's syndrome treated with mycophenolate mofetil. Nephrol Dial Transplant 2000; 15: 920–2
   PubMed Web of Science ®Google Scholar
• Merkel F., Weber M. Successful use of cyclosporin A in progressive anti‐glomerular basement membrane nephritis. Nephrol Dial Transplant 2000; 15: 1714–15
   PubMedGoogle Scholar
• Merkel F., Pullig O., Marx M., Netzer K. O., Weber M. Course and prognosis of anti‐basement membrane antibody (anti‐BM‐Ab)‐mediated disease: report of 35 cases. Nephrol Dial Transplant 1994; 9: 372–6
   PubMed Web of Science ®Google Scholar
• Levy J. B., Turner A. N., Rees A. J., Pusey C. D. Long‐term outcome of anti‐glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001; 134: 1033–42
   PubMed Web of Science ®Google Scholar